[Bladder cancer: understanding the disease and future implications for assessment and therapy].
Since 1940, the evolution in analysis and treatment of bladder cancer refines our staging systems and enhances our capabilities in assessing a diagnosis, a prognosis and in defining appropriate treatments. Such a study implies a critical conceptualisation of tumour developmental pathways, added by the recent observations in molecular biology research.
Droller
M
M
Department of Urology, Mount Sinai Medical Center, One Gustave L. Levy Place, NewYork, NY 10029-6574, USA.
D006801:Humans; D009367:Neoplasm Staging; D001749:Urinary Bladder Neoplasms / Q000235:genetics / Q000473:pathology*